Podcast
Questions and Answers
Which of the following is a criterion for the CURB-65 assessment?
Which of the following is a criterion for the CURB-65 assessment?
What is the main goal of balancing therapy in patient treatment?
What is the main goal of balancing therapy in patient treatment?
For patients at risk of P. aeruginosa, what antibiotic regimen is suggested?
For patients at risk of P. aeruginosa, what antibiotic regimen is suggested?
Which of the following conditions would indicate the need for empiric therapy for MRSA in hospitalized patients with severe CAP?
Which of the following conditions would indicate the need for empiric therapy for MRSA in hospitalized patients with severe CAP?
Signup and view all the answers
What is the purpose of continually monitoring a patient's clinical status and diagnostic data?
What is the purpose of continually monitoring a patient's clinical status and diagnostic data?
Signup and view all the answers
Which antibiotic regimen is recommended for the treatment of Pseudomonas aeruginosa in patients with pneumonia?
Which antibiotic regimen is recommended for the treatment of Pseudomonas aeruginosa in patients with pneumonia?
Signup and view all the answers
What is the maximum duration recommended for treating S.aureus or P.aeruginosa with concomitant bacteremia?
What is the maximum duration recommended for treating S.aureus or P.aeruginosa with concomitant bacteremia?
Signup and view all the answers
In cases of suspected MRSA pneumonia, which additional treatment is recommended?
In cases of suspected MRSA pneumonia, which additional treatment is recommended?
Signup and view all the answers
What does CLSI recommend for isolates of S.pneumonia suspected to be susceptible to intravenous penicillin?
What does CLSI recommend for isolates of S.pneumonia suspected to be susceptible to intravenous penicillin?
Signup and view all the answers
Which of the following is NOT recommended for treating MRSA bacteremia associated with a pulmonary source?
Which of the following is NOT recommended for treating MRSA bacteremia associated with a pulmonary source?
Signup and view all the answers
Which antibiotic should be considered in cases where there is a severe beta-lactam allergy?
Which antibiotic should be considered in cases where there is a severe beta-lactam allergy?
Signup and view all the answers
Which symptom is NOT typically associated with necrotizing or cavitary infiltrates in pneumonia?
Which symptom is NOT typically associated with necrotizing or cavitary infiltrates in pneumonia?
Signup and view all the answers
What dosage of Levofloxacin IV is recommended in pneumonia treatment?
What dosage of Levofloxacin IV is recommended in pneumonia treatment?
Signup and view all the answers
What is one characteristic that may indicate pneumonia during a physical examination?
What is one characteristic that may indicate pneumonia during a physical examination?
Signup and view all the answers
What does a leukocytosis with predominance of polymorphonuclear cells indicate in a patient suspected of pneumonia?
What does a leukocytosis with predominance of polymorphonuclear cells indicate in a patient suspected of pneumonia?
Signup and view all the answers
Which of the following is a goal of pneumonia management?
Which of the following is a goal of pneumonia management?
Signup and view all the answers
Which finding on a chest radiograph is indicative of pneumonia?
Which finding on a chest radiograph is indicative of pneumonia?
Signup and view all the answers
What best describes the concept of antimicrobial treatment in pneumonia management?
What best describes the concept of antimicrobial treatment in pneumonia management?
Signup and view all the answers
What is a potential unintended consequence of antibiotic therapy in pneumonia treatment?
What is a potential unintended consequence of antibiotic therapy in pneumonia treatment?
Signup and view all the answers
What symptom may accompany a patient experiencing tachypnea in pneumonia?
What symptom may accompany a patient experiencing tachypnea in pneumonia?
Signup and view all the answers
What is a common laboratory finding in patients with pneumonia?
What is a common laboratory finding in patients with pneumonia?
Signup and view all the answers
Which antibiotic is preferred for treating methicillin-susceptible strains in community-acquired pneumonia?
Which antibiotic is preferred for treating methicillin-susceptible strains in community-acquired pneumonia?
Signup and view all the answers
What is the treatment of choice for MRSA pneumonia?
What is the treatment of choice for MRSA pneumonia?
Signup and view all the answers
In patients with a hospital-acquired pneumonia prevalence of 20% or greater for MRSA, what coverage should they receive?
In patients with a hospital-acquired pneumonia prevalence of 20% or greater for MRSA, what coverage should they receive?
Signup and view all the answers
Which alternative for MRSA pneumonia has limited clinical evidence?
Which alternative for MRSA pneumonia has limited clinical evidence?
Signup and view all the answers
Which antibiotic is recommended for treating penicillin-intermediate strains?
Which antibiotic is recommended for treating penicillin-intermediate strains?
Signup and view all the answers
What should all empiric hospital-acquired pneumonia regimens include?
What should all empiric hospital-acquired pneumonia regimens include?
Signup and view all the answers
Which pathogen is predominantly responsible for most cases of hospital-acquired pneumonia?
Which pathogen is predominantly responsible for most cases of hospital-acquired pneumonia?
Signup and view all the answers
What should be included for patients at risk of multidrug-resistant strains of hospital-acquired pneumonia?
What should be included for patients at risk of multidrug-resistant strains of hospital-acquired pneumonia?
Signup and view all the answers
What characterizes community-acquired pneumonia (CAP)?
What characterizes community-acquired pneumonia (CAP)?
Signup and view all the answers
Which individuals are most likely to experience impaired lung defenses leading to pneumonia?
Which individuals are most likely to experience impaired lung defenses leading to pneumonia?
Signup and view all the answers
How can lung infections lead to further complications?
How can lung infections lead to further complications?
Signup and view all the answers
What is a potential consequence of alterations in the normal lung microbiome?
What is a potential consequence of alterations in the normal lung microbiome?
Signup and view all the answers
What role do innate and adaptive immunity pathways play in respiratory defenses?
What role do innate and adaptive immunity pathways play in respiratory defenses?
Signup and view all the answers
What is the incidence of multidrug resistance in relation to aureus in pneumonia?
What is the incidence of multidrug resistance in relation to aureus in pneumonia?
Signup and view all the answers
What can lead to the suppression of antibacterial activity in the lungs?
What can lead to the suppression of antibacterial activity in the lungs?
Signup and view all the answers
Which of the following statements about pneumonia is incorrect?
Which of the following statements about pneumonia is incorrect?
Signup and view all the answers
Study Notes
CAP and HAP
- Community-acquired pneumonia (CAP) occurs outside the hospital or within 48 hours of hospital admission.
- Hospital-acquired pneumonia (HAP) occurs 48 hours or more after hospital admission.
- Multidrug resistance is more common in HAP.
- CAP can be caused by S. pneumoniae, H. influenzae, C. pneumoniae, M. pneumoniae, M. catarrhalis, Enteric Gram-negative bacilli, L. pneumophila, Anaerobes, S. aureus, and P. aeruginosa.
- HAP is most commonly caused by gram-negative bacilli, predominantly P. aeruginosa and the Enterobacteriaceae, or S. aureus.
Pathogenesis
- Respiratory host defenses are comprised of innate and adaptive immunity pathways.
- Healthy individuals have robust defense mechanisms, efficiently removing pathogens before infection.
- Immunocompromised individuals lack robust defense mechanisms, increasing susceptibility to infection.
- Lung infections can suppress antibacterial activity, impairing alveolar macrophage function and mucociliary clearance, leading to secondary bacterial pneumonia.
### Pathophysiology
- Urinary antigen tests detect S. pneumoniae in urine and are more rapid than traditional microbiological methods.
Physical Examination
- Tachypnea and tachycardia are common symptoms of pneumonia.
- Dullness to percussion, increased tactile fremitus, whisper pectoriloquy, and egophony are signs of pneumonia.
- Chest wall retractions and grunting respirations indicate respiratory distress.
- Diminished breath sounds over the affected area and inspiratory crackles suggest lung consolidation.
Chest Radiograph
- A dense lobar or segmental infiltrate is characteristic of pneumonia.
Laboratory Tests
- Leukocytosis with predominance of polymorphonuclear cells, elevated white blood cell count, is a common finding.
- Low oxygen saturation on arterial blood gas or pulse oximetry indicates respiratory compromise.
Management of Pneumonia
- Treatment goals: Eradication of the offending organism, minimization of unintended consequences of therapy, and minimizing costs.
General Approach to Treatment
- Antimicrobial treatment involves selecting the right antibiotic at the right time, dose, and duration.
- Continual monitoring of patient clinical status and diagnostic data guides therapy decisions, adjusting or discontinuing treatment as needed.
- CURB-65 and CRB-65 are commonly used severity assessment tools for CAP.
CURB-65
- The CURB-65 score assigns 1 point for each criterion present:
- Confusion
- Uremia (BUN >20 mg/dL or 7.1 mmol/L)
- Respiratory rate ≥30 breaths/min
- Blood pressure (systolic <90 mmHg or diastolic <60 mmHg)
- Age ≥65 years
### Empiric Therapy for CAP
-
Low risk of MRSA:
- Ceftriaxone 2 g IV q24h OR Ertapenem 1g IV q24h PLUS Azithromycin 500mg IV daily OR Levofloxacin 750mg IV daily
- **Risk of MRSA: **
- Piperacillin-tazobactam 4.5g IV q6h OR Cefepime 2g IV q8-12h OR Meropenem 1g IV q8h PLUS Azithromycin 500mg IV daily PLUS (Gentamicin 5-7mg/kg IV daily OR Amikacin 15mg/kg IV daily) OR (Piperacillin-tazobactam 4.5g IV q6h OR Cefepime 2g IV q8-12h OR Meropenem 1g IV q8h) PLUS (Levofloxacin 750mg IV daily OR Ciprofloxacin 400mg IV q8-12h)
-
Suspected MRSA pneumonia:
- ADD Vancomycin 25-30mg/kg loading dose then 15-20mg/kg IV q8-12h OR Linezolid 600mg IV q12h
### Duration of Treatment
- 7-10 days is usually adequate for most pneumonia cases.
- 28 days is possible for S. aureus or P. aeruginosa with concomitant.
Directed Antimicrobial Therapy for Common Pneumonia Pathogens
-
S. pneumoniae: The most common bacterial cause of CAP.
- Narrow-spectrum penicillin (penicillin, ampicillin, or amoxicillin) is preferred for susceptible strains (MIC ≤ 2 mg/L).
- Cephalosporin, macrolides, or anti-pneumococcal fluoroquinolones are alternative options.
- Third-generation cephalosporin or fluoroquinolone is preferred for resistant strains.
- High-dose amoxicillin (3 g/day) may be used for intermediate strains (MIC = 4 mg/L).
### Empiric Therapy for HAP
- All empiric HAP regimens should cover gram-negative bacilli with at least one antibiotic, typically an antipseudomonal, antistaphylococcal β-lactam or an antipseudomonal, antistaphylococcal fluoroquinolone.
- MRSA coverage: If the hospital MRSA prevalence is ≥ 20%, or the patient has risk factors like IV antibiotics in the past 90 days or structural lung disease, vancomycin or linezolid should be added.
- MDR gram-negative coverage: Consider adding a second antipseudomonal agent for patients with MDR risk factors.
Directed Therapy for Important Gram-Negative Pathogens
-
H. influenzae: The most common gram-negative cause of CAP.
- For susceptible strains, oral amoxicillin is commonly used.
- For resistant strains, oral or intravenous cefuroxime, intravenous ceftriaxone, or oral levofloxacin are options.
### Directed Therapy for MRSA Pneumonia
-
Methicillin-susceptible strains:
- Dicloxacillin is preferred.
- Cefazolin is an alternative option with less clinical data.
- Clindamycin or vancomycin may be used but are not preferred.
-
Methicillin-resistant strains (MRSA):
- Vancomycin or linezolid are the treatment of choice.
- Alternatives with limited evidence:
- Quinupristin-dalfopristin
- Ceftaroline
- Sulfamethoxazole-trimethoprim
- Clindamycin
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
Explore the key differences between community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP), including their common causes and associated risks. Understand the role of host defenses in the pathogenesis of pneumonia and how they impact infection susceptibility.